Buck Institute Launches AI-Powered Healthspan Tracking Initiative
New program combines wearables, lab data, and AI to predict healthy aging trajectories and prevent disease before symptoms appear.
29 articles in this topic
New program combines wearables, lab data, and AI to predict healthy aging trajectories and prevent disease before symptoms appear.
Biotech company secures funding to move lab-grown human tissue implants toward clinical trials, starting with adipose tissue.
UK biotech secures major funding for antibody therapy targeting protein buildup that damages hearts in amyloidosis patients.
Rubedo's RLS-1496 demonstrates early clinical signals in removing senescent cells through GPX4 modulation in human skin tissue.
Topical therapy RLS-1496 met primary endpoints in Phase 1 trial with no serious adverse events in psoriasis patients.
Maze Therapeutics' MZE829 reduced kidney damage markers by over 35% in patients with APOL1-mediated kidney disease in Phase 2 trials.
New study of 96,000 people shows brief bursts of intense activity dramatically reduce risks of heart disease, dementia, and diabetes.
Stanford-Buck coalition develops intrinsic capacity score to quantify aging and test interventions through YMCA partnerships.
New research suggests shingles vaccination may offer unexpected anti-aging benefits beyond infection prevention.
New study reveals meat avoidance may reduce centenarian odds in frail seniors, but body weight and protein intake matter more than diet type.
People who stay mentally sharp past 80 carry fewer Alzheimer's risk genes and more protective variants than their peers.
Singapore researchers find calcium alpha-ketoglutarate repairs brain cell communication and restores early memory abilities in Alzheimer's models.